Promoting the development and approval of new traditional Chinese medicines in China: a pooled analysis of data from 2013 to 2024
The reform of the development and approval system for traditional Chinese medicines (TCMs) has been in progress for several years. This reform has restructured the registration classifications and established a distinctive evaluation and registration evidence system for TCMs. This study compiled com...
Saved in:
| Main Authors: | Xiaohong Long, Jie Zhang, Li Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1559703/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics, clinical evidence and implementation effects of conditional approvals for drugs in China, a pooled analysis from 2020 to 2023
by: Li Yang, et al.
Published: (2025-04-01) -
Clinical research report on Chinese patent medicines and classic traditional Chinese medicine prescriptions (2023)
by: Xiaolei Wu, et al.
Published: (2025-06-01) -
Toward better translation of clinical research evidence into rapid recommendations for traditional Chinese medicine interventions: A methodological framework
by: Qianrui Li, et al.
Published: (2022-09-01) -
Traditional Chinese Medicine Treating Dilated Cardiomyopathy: A Literature Review
by: Fan H, et al.
Published: (2025-08-01) -
Advancing human-use experience for real-world evidence for the registration of traditional Chinese medicine products in China
by: Mingge Xia, et al.
Published: (2025-05-01)